These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 6897833)

  • 1. [Bioequivalence of solid drug preparation].
    Ejima A
    Eisei Shikenjo Hokoku; 1982; (100):1-20. PubMed ID: 6897833
    [No Abstract]   [Full Text] [Related]  

  • 2. Doctors are pivotal to prescription struggle.
    Chapman S
    Leg Aspects Med Pract; 1979 Mar; 7(3):42-4. PubMed ID: 423688
    [No Abstract]   [Full Text] [Related]  

  • 3. Striving for standards in bioequivalence assessment: a review.
    Schulz HU; Steinijans VW
    Int J Clin Pharmacol Ther Toxicol; 1991 Aug; 29(8):293-8. PubMed ID: 1743802
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
    Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysis.
    Savoie N; Booth BP; Bradley T; Garofolo F; Hughes NC; Hussain S; King SP; Lindsay M; Lowes S; Ormsby E; Phull R; Rocci ML; Vallano PT; Viau A; Zhu Z
    Bioanalysis; 2009 Apr; 1(1):19-30. PubMed ID: 21083184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic bioequivalence: a scientific consensus needed.
    Am Fam Physician; 1987 Feb; 35(2):91, 95. PubMed ID: 3812175
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological and therapeutic aspects of drug administration by rate-controlled drug delivery systems: steady-state pharmacology.
    Urquhart J
    Boll Chim Farm; 1984 Apr; 123(4):155-68. PubMed ID: 6383428
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenges and opportunities in animal drug development: a regulatory perspective.
    Lathers CM
    Nat Rev Drug Discov; 2003 Nov; 2(11):915-8. PubMed ID: 14560318
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioavailability and bioequivalence requirements: abbreviated applications. Final Rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Dec; 67(244):77668-75. PubMed ID: 12492102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspects for bioavailability and bioequivalence revision: possible implications on clinical pharmacology.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1987 Jul; 9(7):453-9. PubMed ID: 3683020
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bioavailability of drug products and bioequivalence requirements (author's transl)].
    Jaminet F
    J Pharm Belg; 1978; 33(3):141-56. PubMed ID: 682101
    [No Abstract]   [Full Text] [Related]  

  • 12. Levothyroxine dosage and the limitations of current bioequivalence standards.
    Hennessey JV
    Nat Clin Pract Endocrinol Metab; 2006 Sep; 2(9):474-5. PubMed ID: 16957756
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioavailability and bioequivalence.
    Skelly JP
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):539-45. PubMed ID: 977792
    [No Abstract]   [Full Text] [Related]  

  • 14. Aspects of bioavailability and bioequivalence revision: possible implications on clinical pharmacology.
    Glasser AC
    Methods Find Exp Clin Pharmacol; 1987 Jul; 9(7):449-52. PubMed ID: 3683019
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro bioequivalence testing.
    Chow SC; Shao J; Wang H
    Stat Med; 2003 Jan; 22(1):55-68. PubMed ID: 12486751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated drug bioanalysis for human pharmacokinetic studies and therapeutic drug management.
    Huang Y; Shi R; Gee W; Bonderud R
    Bioanalysis; 2012 Aug; 4(15):1919-31. PubMed ID: 22943622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA mulls changes to bioequivalence standards.
    Traynor K
    Am J Health Syst Pharm; 2010 Jun; 67(11):864. PubMed ID: 20484205
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral controlled release preparations.
    García CR; Siqueiros A; Benet LZ
    Pharm Acta Helv; 1978; 53(3-4):99-109. PubMed ID: 360228
    [No Abstract]   [Full Text] [Related]  

  • 19. New toxicological testing approaches based upon exposure/activity/availability assessments.
    Mulligan LT
    Drug Metab Rev; 1995; 27(4):573-9. PubMed ID: 8925718
    [No Abstract]   [Full Text] [Related]  

  • 20. Generic drug substitution revisited.
    Strom BL
    N Engl J Med; 1987 Jun; 316(23):1456-62. PubMed ID: 3553952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.